Jasper Hellweg
Stock Analyst at Argus Research
(2.11)
# 2,959
Out of 5,149 analysts
92
Total ratings
48.61%
Success rate
3.64%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $377.00 | +6.10% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $19.03 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $125.93 | +50.88% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $184.02 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $498.65 | -19.78% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $129.56 | +15.78% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $46.47 | +29.12% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $766.66 | +52.61% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $474.27 | +15.97% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $201.76 | -57.87% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $36.66 | +240.97% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $49.83 | +180.96% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $233.86 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $32.28 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $173.96 | +66.70% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $86.75 | +15.27% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $282.99 | +4.24% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.92 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $208.36 | -35.21% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.39 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $206.43 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $204.24 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $28.05 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $541.80 | -71.39% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $62.89 | +43.11% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $377.00
Upside: +6.10%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $19.03
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $125.93
Upside: +50.88%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $184.02
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $498.65
Upside: -19.78%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $129.56
Upside: +15.78%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $46.47
Upside: +29.12%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $766.66
Upside: +52.61%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $474.27
Upside: +15.97%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $201.76
Upside: -57.87%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $36.66
Upside: +240.97%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $49.83
Upside: +180.96%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $233.86
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $32.28
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $173.96
Upside: +66.70%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $86.75
Upside: +15.27%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $282.99
Upside: +4.24%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.92
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $208.36
Upside: -35.21%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $11.39
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $206.43
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $204.24
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $28.05
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $541.80
Upside: -71.39%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $62.89
Upside: +43.11%